Fabbro, Hahn, Novaes, Ó’Grálaigh and O'Mahony; Cost-Effectiveness Analyses of Lung Cancer Screening Using Low-Dose Computed Tomography: A Systematic Review Assessing Strategy Comparison & Risk Stratification; International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Vienna, November 2022.
Pokharel, Lin, McFerran and O’Mahony. Is biennial colorectal cancer screening an optimal policy choice for Europe? A systematic review of cost-effectiveness analyses; European Health Economics Association 9th Annual EuHEA PhD Conference; Galway, August 2022.
O'Mahony. How Complete is the Evidence that Biennial Mammography in Average Risk Women is Cost-Effective? Revisiting the Literature; International Cancer Screening Conference; Rotterdam, June, 2019.
O'Mahony and Van Rosmalen. A Simplified Model of the Cost-Effectiveness of Screening in R: A Teaching and Research Tool; Society for Medical Decision Making 17th Biennial European Meeting; Leiden, June 2018.
Chen, Wanniarachige, Murphy, Lockhart and O'Mahony. Surveying the Cost-Effectiveness of the Twenty Procedures with the Largest Public Health Services Waiting Lists in Ireland: Implications for Ireland's Cost-Effectiveness Threshold; Society for Medical Decision Making 17th Biennial European Meeting; Leiden, June 2018.
O'Mahony Ten Ways to Enhance the Estimation, Reporting and Interpretation of the Cost-Effectiveness of Cancer Screening Interventions; Society for Medical Decision Making 16th Biennial European Meeting; London, June 2016.
Paulden and O'Mahony The Determinants of Change in the Cost-effectiveness Threshold; Society for Medical Decision Making 16th Biennial European Meeting; London, June 2016.
O'Mahony and Coughlan. The Irish Cost-Effectiveness Threshold: Does it Support Rational Rationing or Might it Lead to Systematic Damage of Ireland's Health System?; the International Society for Pharmacoeconomics and Outcomes Research 17th Annual European Meeting; Amsterdam, November 2014.
O'Mahony. The Need to Revise Dutch Discounting Guidance: Questions of Theory and Practice; Society for Medical Decision Making 15th Biennial European Meeting; Antwerp, June 2014.
O'Mahony. Presenting the results of cost-effectiveness analyses of HPV testing in cervical screening in a more intuitive way; the IFCPC 15th World Congress for Cervical Pathology and Colposcopy; London, May 2014.
O'Mahony and Naber. The cost-effectiveness of HPV testing in cervical screening: why current estimates only tell half the story; the IFCPC 15th World Congress for Cervical Pathology and Colposcopy; London, May 2014.
O'Mahony and O'Neill, The Health of Health Technology Assessment in Ireland: Five Points for Improvement, the International Society for Pharmacoeconomics and Outcomes Research 16th Annual European Meeting; Dublin, November 2013.
O’Mahony, Naber, and de Kok. Critical Appraisal of Cost-Effectiveness Analyses of Human Papillomavirus Testing in Cervical Screening: Making Appropriate Comparisons and Usefully Interpreting Results, ISPOR 16th Annual European Congress; Dublin, Ireland, November 2013.
O'Mahony. Critical Appraisal of Cost-Effectiveness Analyses of Human Papillomavirus Testing in Cervical Screening: Appropriate Comparisons and the Useful Interpretations of Results, 35th Annual North American Meeting of the Society for Medical Decision Making; Baltimore, October 2013.
O'Mahony and Paulden. NICE's Selective Application of Differential Discounting: Ambiguous, Inconsistent and Unjustified, ISPOR 18th Annual International Meeting; Patient-Centered Outcomes: Focusing on the Patient; New Orleans, May 2013.
O’Mahony. Revisiting HPV Vaccination: Why Existing CEAs Underestimate the Vaccine's Cost-Effectiveness and Incorrectly Estimate its Threshold Price; the International Society for Pharmacoeconomics and Outcomes Research 13th Annual European Meeting; Madrid, November 2011.
O’Mahony. Differential Discounting: Questioning the Assumption of Healthcare Resource Fungibility over Time; the International Society for Pharmacoeconomics and Outcomes Research 13th Annual European Meeting; Madrid, November 2011.
O’Mahony. Should We Aggregate Cost-Effectiveness over an Intervention's Entire Implementation Lifetime?; the International Society for Pharmacoeconomics and Outcomes Research 13th Annual European Meeting; Madrid, November 2011.
O’Mahony & van Rosmalen. How Cost-Effectiveness Acceptability Curves Vary with the Number of Treatment Strategies Compared and Why This Compromises Their Usefulness; the Society of Medical Decision Making 33rd North American Meeting, Chicago, October 2011.
O’Mahony & van Rosmalen. The Discrete Modelling of Interventions with Continuously Varying Costs and Effects: Implications for ICERs, CEACs and EVPI; the International Society for Pharmacoeconomics and Outcomes Research 16th Annual International Meeting; Baltimore, May 2011.
O’Mahony, JF & van Rosmalen, J. Does Differential Discounting Enhance Decision Making?; the International Society for Pharmacoeconomics and Outcomes Research 16th Annual International Meeting; Baltimore, May 2011.